tirzepatide for kidney disease New drugs emerge in the fight against CKD What are the limitations and

10.1002/glia.22773 Glia

Not the fear-based version that treats every injection like a guaranteed medical disaster

Clinical trials show users lose both visceral fat (deep abdominal fat) and subcutaneous fat (under the skin), proving the medication mobilizes existing reserves

Dr Sultan also recommends physician developed supporting supplements that enhance GLP 1 therapy and promote overall metabolic health

Additionally, since both Semaglutide and alcohol can affect liver function, there is a concern about the added strain on the liver when they are used concurrently

However, because only a small number of women have been studied, it is not yet known if these medicines are completely safe during breastfeeding, especially for newborn or premature babies